Increased DJ-1 in urine exosome of Korean males with Parkinson's disease

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Ho, Dong Hwan ^a,b   Yi, Sanghak ^a   Seo, Hyemyung ^b   Son, Ilhong ^a   Seol, Wongi ^a  

^a Wonkwang University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BIOLOGICAL MARKER; DJ 1 PROTEIN; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; LRRK2 PROTEIN, HUMAN; ONCOPROTEIN; PARK7 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; EXOSOME; FEMALE; HUMAN; KOREAN (PEOPLE); MALE; PARKINSON DISEASE; PROTEIN EXPRESSION; SEX DIFFERENCE; URINALYSIS; WESTERN BLOTTING; AGED; BIOSYNTHESIS; METABOLISM; MUTATION; PATHOLOGY; SEXUAL DEVELOPMENT; SOUTH KOREA; URINE;

AGED; ALPHA-SYNUCLEIN; EXOSOMES; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUTATION; ONCOGENE PROTEINS; PARKINSON DISEASE; PROTEIN-SERINE-THREONINE KINASES; REPUBLIC OF KOREA; SEX CHARACTERISTICS;

EID: 84912535407     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/704678     Document Type: Article

References (39)

1. Zesiewicz T. A., Baker M. J., Wahba M., Hauser R. A., Autonomic nervous system dysfunction in Parkinson's disease. Current Treatment Options in Neurology 2003 5 2 149 160 10.1007/s11940-003-0005-0
2. Pfeiffer R. F., Gastrointestinal dysfunction in Parkinson's disease. Parkinsonism and Related Disorders 2011 17 1 10 15 10.1016/j.parkreldis.2010.08.003 2-s2.0-78651096332
3. Garcia-Ruiz P. J., Chaudhuri K. R., Martinez-Martin P., Non-motor symptoms of Parkinson's disease A review.from the past. Journal of the Neurological Sciences 2014 338 1-2 30 33 10.1016/j.jns.2014.01.002 2-s2.0-84896704036
4. Russo I., Bubacco L., Greggio E., Exosomes-associated neurodegeneration and progression of Parkinson's disease. American Journal of Neurodegenerative Disease 2012 1 3 217 225
5. Hoorn E. J., Pisitkun T., Zietse R., Gross P., Frokiaer J., Wang N. S., Gonzales P. A., Star R. A., Knepper M. A., Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology 2005 10 3 283 290 10.1111/j.1440-1797.2005.00387.x 2-s2.0-21344441046
6. Zhou H., Yuen P. S. T., Pisitkun T., Gonzales P. A., Yasuda H., Dear J. W., Gross P., Knepper M. A., Star R. A., Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney International 2006 69 8 1471 1476 10.1016/j.polymdegradstab.2005.10.005 2-s2.0-33646161950
7. Knepper M. A., Pisitkun T., Exosomes in urine: who would have thought.? Kidney International 2007 72 9 1043 1045 10.1038/sj.ki.5002510 2-s2.0-35348938217
8. Martin I., Dawson V. L., Dawson T. M., Recent advances in the genetics of parkinson's disease. Annual Review of Genomics and Human Genetics 2011 12 301 325 10.1146/annurev-genom-082410-101440 2-s2.0-79960361814
9. Seol W., Biochemical and molecular features of LRRK2 and its pathophysiological roles in Parkinson's disease. BMB Reports 2010 43 4 233 244 10.5483/BMBRep.2010.43.4.233 2-s2.0-77953530143
10. Fraser K. B., Moehle M. S., Daher J. P. L., Webber P. J., Williams J. Y., Stewart C. A., Yacoubian T. A., Cowell R. M., Dokland T., Ye T., Chen D., Siegal G. P., Galemmo R. A., Tsika E., Moore D. J., Standaert D. G., Kojima K., Mobley J. A., West A. B., LRRK2 secretion in exosomes is regulated by 14-3-3. Human Molecular Genetics 2013 22 24 4988 5000 ddt346 10.1093/hmg/ddt346 2-s2.0-84888181176
11. Pisitkun T., Shen R.-F., Knepper M. A., Identification and proteomic profiling of exosomes in human urine. Proceedings of the National Academy of Sciences of the United States of America 2004 101 36 13368 13373 10.1073/pnas.0403453101 2-s2.0-4444226979
12. Kasuga K., Nishizawa M., Ikeuchi T., α -synuclein as CSF and blood biomarker of dementia with lewy bodies. International Journal of Alzheimer's Disease 2012 2012 9 437025 10.1155/2012/437025 2-s2.0-84874894136
13. Tokuda T., Qureshi M. M., Ardah M. T., Varghese S., Shehab S. A. S., Kasai T., Ishigami N., Tamaoka A., Nakagawa M., El-Agnaf O. M. A., Detection of elevated levels of α -synuclein oligomers in CSF from patients with Parkinson disease. Neurology 2010 75 20 1766 1772 10.1212/WNL.0b013e3181fd613b 2-s2.0-78649990079
14. Chartier-Harlin M.-C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destée A., α -synuclein locus duplication as a cause of familial Parkinson's disease. The Lancet 2004 364 9440 1167 1169 10.1016/S0140-6736(04)17103-1 2-s2.0-4644290985
15. Singleton A. B., Farrer M., Johnson J., α -synuclein locus triplication causes parkinson's disease. Science 2003 302 5646 841 10.1126/science.1090278 2-s2.0-0242300619
16. Fuchs J., Nilsson C., Kachergus J., Munz M., Larsson E.-M., Schüle B., Langston J. W., Middleton F. A., Ross O. A., Hulihan M., Gasser T., Farrer M. J., Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 2007 68 12 916 922 10.1212/01.wnl.0000254458.17630.c5 2-s2.0-34147109175
17. Daniel S. E., Lees A. J., Parkinson's Disease Society Brain Bank, London: overview and research. Journal of Neural Transmission: Supplementum 1993 39 165 172 2-s2.0-0027337422
18. Wang Z., Hill S., Luther J. M., Hachey D. L., Schey K. L., Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT). Proteomics 2012 12 2 329 338 10.1002/pmic.201100477 2-s2.0-84862956256
19. Cheruvanky A., Zhou H., Pisitkun T., Kopp J. B., Knepper M. A., Yuen P. S. T., Star R. A., Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. The American Journal of Physiology-Renal Physiology 2007 292 5 F1657 F1661 10.1152/ajprenal.00434.2006 2-s2.0-34247872835
20. Chen C. Y., Hogan M. C., Ward C. J., Purification of exosome-like vesicles from urine. Methods in Enzymology 2013 524 225 241 10.1016/B978-0-12-397945-2.00013-5 2-s2.0-84875279077
21. Merchant M. L., Powell D. W., Wilkey D. W., Cummins T. D., Deegens J. K., Rood I. M., McAfee K. J., Fleischer C., Klein E., Klein J. B., Microfiltration isolation of human urinary exosomes for characterization by MS. Proteomics: Clinical Applications 2010 4 1 84 96 10.1002/prca.200800093 2-s2.0-77951749357
22. Santucci L., Candiano G., Bruschi M., Bodria M., Murtas C., Petretto A., Ghiggeri G. M., Urinary proteome in a snapshot: normal urine and glomerulonephritis. Journal of Nephrology 2013 26 4 610 616 10.5301/jn.5000233 2-s2.0-84880082960
23. Julian B. A., Suzuki H., Suzuki Y., Tomino Y., Spasovski G., Novak J., Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease. Proteomics-Clinical Applications 2009 3 9 1029 1043 10.1002/prca.200800243 2-s2.0-70350776983
24. Caranci G., Piscopo P., Rivabene R., Traficante A., Riozzi B., Castellano A. E., Ruggieri S., Vanacore N., Confaloni A., Gender differences in Parkinson's disease: focus on plasma alpha-synuclein. Journal of Neural Transmission 2013 120 8 1209 1215 10.1007/s00702-013-0972-6 2-s2.0-84881099688
25. Su E., Bell M. J., Wisniewski S. R., Adelson P. D., Janesko-Feldman K. L., Salonia R., Clark R. S. B., Kochanek P. M., Kagan V. E., Bayir H., α -synuclein levels are elevated in cerebrospinal fluid following traumatic brain injury in infants and children: the effect of therapeutic hypothermia. Developmental Neuroscience 2011 32 5-6 385 395 10.1159/000321342 2-s2.0-79951811787
26. Simunovic F., Yi M., Wang Y., Stephens R., Sonntag K. C., Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease. PLoS ONE 2010 5 1 e8856 10.1371/journal.pone.0008856 2-s2.0-77749309959
27. Tokuda T., Salem S. A., Allsop D., Mizuno T., Nakagawa M., Qureshi M. M., Locascio J. J., Schlossmacher M. G., El-Agnaf O. M. A., Decreased α -synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease. Biochemical and Biophysical Research Communications 2006 349 1 162 166 10.1016/j.bbrc.2006.08.024 2-s2.0-33748325848
28. Kordower J. H., Olanow C. W., Dodiya H. B., Chu Y., Beach T. G., Adler C. H., Halliday G. M., Bartus R. T., Disease duration and the integrity of the nigrostriatal system in Parkinson's disease. Brain 2013 136 8 2419 2431 10.1093/brain/awt192 2-s2.0-84880932230
29. Properzi F., Logozzi M., Fais S., Exosomes: the future of biomarkers in medicine. Biomarkers in Medicine 2013 7 5 769 778 10.2217/bmm.13.63 2-s2.0-84884585784
30. Cuevas S., Zhang Y., Yang Y., Escano C., Asico L., Jones J. E., Armando I., Jose P. A., Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension 2012 59 2 446 452 10.1161/HYPERTENSIONAHA.111.185744 2-s2.0-84856084804
31. Paisán-Ruíz C., Jain S., Evans E. W., Gilks W. P., Simón J., Van Der Brug M., De Munain A. L., Aparicio S., Gil A. M., Khan N., Johnson J., Martinez J. R., Nicholl D., Carrera I. M., Peňa A. S., De Silva R., Lees A., Martí-Massó J. F., Pérez-Tur J., Wood N. W., Singleton A. B., Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004 44 4 595 600 10.1016/j.neuron.2004.10.023 2-s2.0-8844266996
32. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R. J., Calne D. B., Stoessl A. J., Pfeiffer R. F., Patenge N., Carbajal I. C., Vieregge P., Asmus F., Müller-Myhsok B., Dickson D. W., Meitinger T., Strom T. M., Wszolek Z. K., Gasser T., Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004 44 4 601 607 10.1016/j.neuron.2004.11.005 2-s2.0-8844233579
33. Park M. J., Cheon S.-M., Bae H.-R., Kim S.-H., Kim J. W., Elevated levels of α -synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease. Journal of Clinical Neurology 2011 7 4 215 222 10.3988/jcn.2011.7.4.215 2-s2.0-84862916400
34. Clements C. M., McNally R. S., Conti B. J., Mak T. W., Ting J. P.-Y., DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proceedings of the National Academy of Sciences of the United States of America 2006 103 41 15091 15096 10.1073/pnas.0607260103 2-s2.0-33750052885
35. Saito Y., Oxidized DJ-1 as a possible biomarker of Parkinson's disease. Journal of Clinical Biochemistry and Nutrition 2014 54 3 138 144 10.3164/jcbn.13-108 2-s2.0-84900397759
36. Kang W. Y., Yang Q., Jiang X. F., Chen W., Zhang L. Y., Wang X. Y., Zhang L. N., Quinn T. J., Liu J., Chen S. D., Salivary DJ-1 could be an indicator of Parkinson's disease progression. Frontiers in Aging Neuroscience 2014 6 102
37. Lin X., Cook T. J., Zabetian C. P., Leverenz J. B., Peskind E. R., Hu S.-C., Cain K. C., Pan C., Edgar J. S., Goodlett D. R., Racette B. A., Checkoway H., Montine T. J., Shi M., Zhang J., DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease. Scientific Reports 2012 2, article 954 10.1038/srep00954 2-s2.0-84871820127
38. Cantuti-Castelvetri I., Keller-McGandy C., Bouzou B., Asteris G., Clark T. W., Frosch M. P., Standaert D. G., Effects of gender on nigral gene expression and parkinson disease. Neurobiology of Disease 2007 26 3 606 614 10.1016/j.nbd.2007.02.009 2-s2.0-34248595527
39. Baldereschi M., Di Carlo A., Rocca W. A., Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. Neurology 2000 55 9 1358 1363 10.1212/WNL.55.9.1358 2-s2.0-0034649437